Search

everythinglearnresearchcommunity

for

Search:↓

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

New alopecia treatments aim for better results and fewer side effects.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

People with Alopecia Areata have a higher risk of heart-related health issues.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Dupilumab for skin problems might reactivate hair loss in some patients.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Tailored combination therapy improves non-scarring alopecia outcomes.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.

We need better research to improve alopecia treatment and patient care.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

Female hair loss patients more likely to have dry eye and gland issues.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Men with Kennedy disease have less chance of hair loss.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.